GLP-1 Receptor
Also known as: GLP-1R · glucagon-like peptide-1 receptor
A G-protein coupled receptor activated by glucagon-like peptide-1, expressed primarily in pancreatic beta cells, the central nervous system, and gastrointestinal tract.
GLP-1 receptor activation drives the full cascade associated with GLP-1 analog research: glucose-dependent insulin secretion, suppressed glucagon release, delayed gastric emptying, and central satiety signaling. The receptor is highly conserved across tissues but produces different downstream effects in each — which is why a single-compound intervention can simultaneously affect blood glucose, appetite, and gastric motility.
Research on GLP-1R desensitization has emerged as a major practitioner concern. Prolonged high-dose receptor agonism appears to downregulate receptor density in some tissues, which is the mechanistic basis for cycling arguments in long-term protocol design.
Related Terms
GIP Receptor
A G-protein coupled receptor activated by glucose-dependent insulinotropic polypeptide, expressed in adipose tissue, pancreatic beta cells, and brain.
GLP-1 Agonist
A class of peptides that activates the GLP-1 receptor, researched for effects on glucose regulation, gastric motility, and appetite signaling.
Receptor Desensitization
The reduction in receptor responsiveness over time due to sustained or high-dose agonist exposure.
Receptor Agonist
A molecule that binds to a receptor and triggers the same biological response as the endogenous ligand.
Look up any peptide term inside DoseCraft Pro
The glossary is just the start. Inside DoseCraft you get 90+ compound deep-dives, a PK-aware protocol engine, interaction checker, and vendor trust scores — every term surfaced in protocol-design context, not a separate page.
Start Free Trial